Skin, pigment and the rest of us
A kidney complicates Age Defying Peptides
A report of kidney injury sits awkwardly beside the wish for younger-looking skin. I think that awkwardness deserves room in the picture.
The kidney case
A 2020 case report described renal infarction associated with Melanotan II use. An infarction is an injury caused by interrupted blood supply. The authors considered a possible clotting effect and possible direct toxicity to kidney tissue; their review also noted earlier reports of severe muscle breakdown and kidney failure. They considered Melanotan II the most likely explanation in this case. The mechanism remained uncertain.
A tan is easy to picture. A kidney losing its blood supply is harder to fit into the same conversation, yet both appear in the literature surrounding this pigment-signalling peptide. I distrust the beauty discussion once the kidney has been cropped out. A case report cannot establish how often an injury happens, and it cannot settle every question of cause. It can still make a cosmetic ambition much harder to treat casually.
Smoother skin, fuller hair
I can understand wanting a smoother face. So does wanting a scar to fade or thinning hair to look fuller. The trouble starts when the visible result becomes the whole account of what a substance does.
GHK-Cu stimulates collagen synthesis in cultured human fibroblasts, the cells that make much of skin's supporting material. There are also small human topical studies. Melanotan II activates a broader melanocortin system, reaching beyond pigment into appetite and sexual response. GLOW combines GHK-Cu with BPC-157 and TB-500, while human safety evidence for these unapproved repair peptides remains scarce.
Those are separate records. The kidney case concerns Melanotan II; it supplies no evidence that a copper-peptide cream causes the same harm. Extending an ingredient's topical history to an injected mixture asks me to infer safety from the wrong preparation.
What a skin result can carry
The GHK-Cu finding I take seriously is quite specific: a review reports increased procollagen synthesis in 70% of treated subjects, compared with 50% for vitamin C and 40% for retinoic acid. Procollagen is a precursor to collagen. These are proportions of people with a measured response, not percentages by which their wrinkles disappeared.
That is an interesting result at its own size. An assertion that an entire body has become younger asks it to carry far more. I would reconsider the broader claims after seeing broader human outcomes measured directly.
GHK-Cu, GLOW and Melanotan II
The GHK-Cu page stays close to skin: collagen-making cells, topical preparations and a hair study whose second ingredient deserves credit. The GLOW page examines what gets added when a cosmetic peptide joins a repair mixture. The Melanotan II page follows the kidney case into pigment changes and the wider safety record.
For a comparison of the actual outcomes, there is skin outcomes, internal effects. None of these compounds has FDA approval for the anti-ageing uses discussed here. Medical decisions require a licensed clinician; this site offers no treatment advice.